Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Qiagen NV QGEN

Technology Scientific & Technical Instruments
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic... see more

Recent & Breaking News (NYSE:QGEN)

QGEN SHAREHOLDER ALERT: Hagens Berman Notifies Investors in Qiagen (QGEN) of an Investigation Involving Possible Securities Law Violations

PR Newswire October 8, 2019

Bragar Eagel & Squire, P.C. is Investigating Qiagen, Inc. (NYSE: QGEN) on Behalf of Qiagen Stockholders and Encourages Qiagen Investors to Contact the Firm

Business Wire October 8, 2019

EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Announces Investigation of Securities Claims Against QIAGEN N.V. - QGEN

Business Wire October 8, 2019

QGEN LOSSES ALERT: Bernstein Liebhard LLP Announces An Investigation of Qiagen N.V.

ACCESSWIRE IA October 8, 2019

SHAREHOLDER ALERT: Gardy & Notis, LLP Investigation Of Shareholder Claims Against Qiagen (NYSE: QGEN)

PR Newswire October 8, 2019

QIAGEN and Illumina Partner to Deliver Sequencing-Based In-Vitro Diagnostic (IVD) Tests

Business Wire October 7, 2019

QIAGEN Announces CEO Leadership Transition

Business Wire October 7, 2019

QIAGEN Reports Preliminary Q3 2019 Results and Announces Measures to Prioritize Resource Allocation

Business Wire October 7, 2019

Illumina and QIAGEN Partner to Deliver Sequencing-Based In-Vitro Diagnostic (IVD) Tests

Business Wire October 7, 2019

QIAGEN Launches Enhanced GeneGlobe Design & Analysis Hub, Combining Curated Knowledge, Content-based Assays and Analyses for Life Science Research

Business Wire September 30, 2019

QIAGEN Announces Change in Global Sales Structure

Business Wire September 10, 2019

QIAGEN's New QIAstat-Dx Gastrointestinal Panel Demonstrates Excellent Performance in Multicenter Clinical Study in Europe

Business Wire August 14, 2019

QIAGEN reports full results for second quarter and first half of 2019

Business Wire July 30, 2019

QIAGEN Reports Results for Second Quarter of 2019; Updates Full-Year 2019 Outlook Due to Decision to Restructure China NGS Partnership

Business Wire July 24, 2019

QIAGEN N.V. to Report Second Quarter and First Half of 2019 Results

Business Wire July 16, 2019

QIAGEN Clinical Insight Surpasses 1 Million Patient Test Cases Analyzed and Interpreted

Business Wire June 20, 2019

QIAGEN and McKesson Agree to Distribute QIAstat-Dx Syndromic Testing Solution to Smaller Hospitals and Other Select Segments in the United States

Business Wire June 19, 2019

QIAGEN to deliver genomic insights for Japan's new molecular oncology clinical research and precision medicine initiative

Business Wire June 18, 2019

QIAGEN and DiaSorin collaborate on novel QuantiFERON-based test with breakthrough potential for earlier detection of Lyme disease

Business Wire June 5, 2019

QIAGEN launches first FDA-approved companion diagnostic for PIK3CA biomarkers to enhance precision medicine in breast cancer

Business Wire May 24, 2019